| Cmhc Cloverdale | |
|
140 S Cloverdale Blvd Cloverdale CA 95425 | |
| (707) 894-4715 | |
| Not Available |
| Full Name | Cmhc Cloverdale |
|---|---|
| Speciality | Clinic/Center |
| Location | 140 S Cloverdale Blvd, Cloverdale, California |
| Authorized Official Name and Position | Ruby Zhang (DEPARTMENT ANALYST) |
| Authorized Official Contact | 7075657846 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Cmhc Cloverdale 1360 N Mcdowell Blvd Ste 1a Petaluma CA 94954-1177 Ph: (707) 894-4715 | Cmhc Cloverdale 140 S Cloverdale Blvd Cloverdale CA 95425 Ph: (707) 894-4715 |
| NPI Number | 1952637027 |
|---|---|
| Provider Enumeration Date | 10/26/2009 |
| Last Update Date | 05/23/2023 |
| Medicare PECOS PAC ID | 4688658651 |
|---|---|
| Medicare Enrollment ID | O20040616001152 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952637027 | NPI | - | NPPES |
| 49FP | Other | CA | PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | (* (Not Available)) | Primary |
| Provider Name | Jennifer P Beck |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669523387 PECOS PAC ID: 5597655647 Enrollment ID: I20040319001247 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Tess M Lusher |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548210099 PECOS PAC ID: 3072597087 Enrollment ID: I20040616001469 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Gary Bravo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669536009 PECOS PAC ID: 3678557592 Enrollment ID: I20040616001594 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Neil P Ehrlich |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013078625 PECOS PAC ID: 2163401464 Enrollment ID: I20040719001651 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Lennart H Moller |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336224237 PECOS PAC ID: 3072560358 Enrollment ID: I20050407001357 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Michael Kozart |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013060888 PECOS PAC ID: 1456392927 Enrollment ID: I20050513000814 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Danielle Marie Pyevich |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1689764029 PECOS PAC ID: 5092785964 Enrollment ID: I20060201000143 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Clare L Maxwell |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548452519 PECOS PAC ID: 2961566682 Enrollment ID: I20090126000125 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Zoe Martinez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1740319581 PECOS PAC ID: 9234280959 Enrollment ID: I20090619000189 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Diana L Verde |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1235347576 PECOS PAC ID: 5395896278 Enrollment ID: I20090707000040 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Daniel B Bleman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1154479996 PECOS PAC ID: 8729059761 Enrollment ID: I20091209000711 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Paul Mascovich |
|---|---|
| Provider Type | Practitioner - Neuropsychiatry |
| Provider Identifiers | NPI Number: 1215921184 PECOS PAC ID: 5597775791 Enrollment ID: I20100504000194 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Mary Margaret Ewing |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1073652004 PECOS PAC ID: 9739375346 Enrollment ID: I20101122000902 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Naomi Granvold |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1356425326 PECOS PAC ID: 6608065578 Enrollment ID: I20110107000016 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Neal H Adams |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1659407823 PECOS PAC ID: 7911189824 Enrollment ID: I20110315000208 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Tiffany Y Tsai |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1043483431 PECOS PAC ID: 5092986778 Enrollment ID: I20110929000575 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Susan L Ahart |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407924475 PECOS PAC ID: 8921268285 Enrollment ID: I20120322000678 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Nakul Varshney |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1942413463 PECOS PAC ID: 1052564895 Enrollment ID: I20130103000463 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Jill Rothberg |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811044407 PECOS PAC ID: 5496978512 Enrollment ID: I20140519000729 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Sophie Aneson-macleon |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316007156 PECOS PAC ID: 0345463907 Enrollment ID: I20140529000453 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Lisa M Walker |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1154399723 PECOS PAC ID: 4082706890 Enrollment ID: I20161021001371 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Naga Kothapalli |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1619301579 PECOS PAC ID: 4284934761 Enrollment ID: I20170628002707 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Angela Burt |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1992890222 PECOS PAC ID: 2567428618 Enrollment ID: I20170707000410 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Benjamin Ross Goldstein |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1982915963 PECOS PAC ID: 2365660297 Enrollment ID: I20180207002747 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Katherine Cole |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1447469192 PECOS PAC ID: 1850487406 Enrollment ID: I20180208002959 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | David Nichols |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588933592 PECOS PAC ID: 0648531095 Enrollment ID: I20180227000765 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Matthew J Gardiner |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629084710 PECOS PAC ID: 9133148794 Enrollment ID: I20190220002910 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Larissa A Pendergraft |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932404902 PECOS PAC ID: 6608107115 Enrollment ID: I20191015001956 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Kevin S Zhang |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225370885 PECOS PAC ID: 6103258751 Enrollment ID: I20191119003333 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Victoria I Ojiako |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508403551 PECOS PAC ID: 3971934910 Enrollment ID: I20200507002148 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Divya Krishnamoorthy |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1194742825 PECOS PAC ID: 9830192871 Enrollment ID: I20200513001409 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Himabindu Ravi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629152541 PECOS PAC ID: 1759357775 Enrollment ID: I20201201001404 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Katie Blake |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1104375393 PECOS PAC ID: 9436562345 Enrollment ID: I20210114001698 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Leonora K. Petty |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1194778894 PECOS PAC ID: 1153341946 Enrollment ID: I20210913002095 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Oluseun Ofuje Ajayi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114389178 PECOS PAC ID: 5193011591 Enrollment ID: I20210917002848 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
| Provider Name | Thomas Kim |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1346653664 PECOS PAC ID: 4981934163 Enrollment ID: I20220218002415 |
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
News Archive
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Researchers have uncovered a crucial link between dietary zinc intake and protection against Streptococcus pneumoniae, the primary bacterial cause of pneumonia.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.
With this summer slated to be the hottest on record, more and more people, especially farmworkers, are at even higher risks of heatstroke.
› Verified 3 days ago
Alexander Valley Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 6 Tarman Dr, Cloverdale, CA 95425 Phone: 707-894-4229 | |
Alexander Valley Healthcare Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Tarman Dr, Cloverdale, CA 95425 Phone: 707-894-4229 Fax: 707-894-2954 | |
Alexander Valley Healthcare Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Tarman Drive, Cloverdale, CA 95425 Phone: 707-894-4229 Fax: 707-894-2954 | |
Alexander Valley Healthcare Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 E 1st St, Cloverdale, CA 95425 Phone: 707-894-4229 Fax: 707-894-2954 | |
Alexander Valley Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 W 3rd St, Cloverdale, CA 95425 Phone: 707-894-4229 |